Provided by Tiger Trade Technology Pte. Ltd.

Summit Therapeutics PLC

16.91
+0.52003.17%
Post-market: 16.920.0100+0.06%19:58 EDT
Volume:13.06M
Turnover:224.22M
Market Cap:13.49B
PE:-15.13
High:17.72
Open:16.59
Low:16.17
Close:16.39
52wk High:29.23
52wk Low:12.07
Shares:797.75M
Float Shares:152.34M
Volume Ratio:1.41
T/O Rate:8.57%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.1177
EPS(LYR):-1.4439
ROE:-192.50%
ROA:-101.61%
PB:21.41
PE(LYR):-11.71

Loading ...

Feb 25, 2021

Major Issues Report

8-K - Current report
Feb 16, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 15, 2021

Correspondence

CORRESP [Cover] - Correspondence
Nov 25, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Nov 24, 2020

Major Issues Report

8-K/A [Amend] - Current report
Nov 23, 2020

Major Issues Report

8-K - Current report
Nov 16, 2020

Major Issues Report

8-K - Current report
Nov 16, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 13, 2020

Major Issues Report

8-K - Current report
Nov 13, 2020

Major Issues Report

8-K - Current report
Nov 10, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Nov 10, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Nov 06, 2020

Major Issues Report

8-K - Current report
Oct 13, 2020

Correspondence

CORRESP [Cover] - Correspondence
Oct 07, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Oct 05, 2020

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Oct 05, 2020

Employee Stock Ownership

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Oct 05, 2020

Major Issues Report

8-K - Current report
Sep 29, 2020

Major Issues Report

8-K - Current report
Sep 29, 2020

Major Issues Report

8-K - Current report